Carmela Mendoza
Carmela Mendoza is a senior reporter for Private Equity International based in London. She first joined PEI in Hong Kong in 2015 and covered Asia. A graduate of Ateneo de Manila University, she previously worked for a digital agency in Singapore focused on government websites and publications covering business, trade and industry, transport, and social development.
Healthcare investor ChrysCapital sold its stake in Delhi-based pharmaceuticals company Mankind Pharma to investment firm Capital International for $190 million.
The alternative investment management firm has appointed Steve An to lead client support and business development at its first office in South Korea.
Guangdong-based Yuehai and KKR are partnering to expand the company’s operations and provide safe and high-quality aquatic feed to the country’s large base of fish farmers and suppliers.
%2080.jpg "Golden Equator Capital to close first tech fund in early 2016")
The asset management and private equity company is planning to launch a second technology and innovation fund in the first quarter of the year.
The firm’s acquisition of Avendus Capital, which owns Avendus PE Investment Advisors, will help scale up the merchant bank and fund its credit solutions business.
The Indian firm’s current fund is three-quarters invested in India-based healthcare and life sciences companies.
First Avenue has recently opened an office in Hong Kong and appointed former Park Hill Group managing director, Michael Henningsen, as partner to lead its operations, according to a statement.
The firm began marketing its SEAF India Agribusiness International Fund II in September targeting $150 million. The fund will invest $20 million to $25 million in small and medium enterprises, including food supply and other agribusinesses in India.
Southeast Asia and India focused private equity firm Creador has made a partial exit from its investment in financial services provider Cholamandalam generating an internal rate of return of 33 percent.
Over the last three years, investments from Asian sovereign wealth funds amount to more than 50 percent of the firm’s SWF commitments. The private equity giant is receiving more commitments from SWFs than historically it has ever done, Carlyle co-founder David Rubenstein said during the firm’s third quarter earnings call.